www.ista2012.com.br

Ponto Zoom
OCTOBER 18 to 19, 2012
OUROMINAS HOTEL BELO HORIZONTE
MINAS GERAIS BRAZIL
Organization
Special Support
Co-Chairs
Richard C. Becker (USA)
Duke University
Renato D. Lopes (USA)
Duke University
Federal University of Sao Paulo (UNIFESP-EPM)
David A. Garcia (USA)
University of New Mexico
Brazilian Co-Chairs
Marcia M. Barbosa
Maria da Consolação V. Moreira
Otavio Berwanger
Sociedade Interamericana de Cardiologia
Universidade Federal de Minas Gerais
Instituto de Ensino e Pesquisa HCor
Language
English is the official language of the Symposium
Tradução Simultânea em Português
On Line Registration
www.ista2012.com.br
Support
Symposium Secretariat:
BCRI - Brazilian Clinical Research Institute
+ 55 11
5904 7339
Fax: + 55 11 5904 7331
www.ista2012.com.br
[email protected]
OCTOBER 18 to 19, 2012
OUROMINAS HOTEL BELO HORIZONTE
MINAS GERAIS BRAZIL
Message from the Directors
As the directors of the Brazilian Clinical Research Institute (BCRI) and
Duke Clinical Research Institute (DCRI), we are honored to welcome
you to the 5th. INTERNATIONAL SYMPOSIUM OF THROMBOSIS AND
ANTICOAGULATION - ISTA 2012.
The main purpose of this symposium is to bring
forward the most recent evidence relevant
to
thrombosis
and
antithrombotic
therapy
into a framework directly applicable to your
current clinical practice. The expert faculty will
also provide state of the art insights into new
therapeutic agents under development as well as
novel diagnostic tools in the field. With a faculty that includes internationally
and nationally recognized clinician-investigators, this meeting provides a
unique opportunity to become aware of the latest knowledge and expert
opinion pertinent to this field.
Our major objective is to focus on clinical decision-making; the faculty will
strive to offer you practical answers that will help with patient management
on a day-to-day basis. We hope you enjoy this scientific program and take
advantage of the presence of our expert national and international faculty
to enhance your knowledge and effectively apply it for the benefit of your
patients.
Antonio Carlos Lopes MD PhD
Professor of Medicine
Director, Brazilian Clinical Research Institute
Eric Peterson MD
Professor of Medicine
Director, Duke Clinical Research Institute
CO-CHAIRS
Renato D. Lopes
Duke University (USA)
Federal University of Sao Paulo (UNIFESP-EPM)
Richard C. Becker
Duke University (USA)
David A. Garcia
University of New Mexico (USA)
BRAZILIAN CO-CHAIRS
Marcia M. Barbosa
Sociedade Interamericana de Cardiologia
Maria da Consolação V. Moreira
Universidade Federal de Minas Gerais
Otavio Berwanger
Hospital do Coracao (HCor) Sao Paulo
INTERNATIONAL FACULTY
Christopher Granger (USA)
David A. Garcia (USA)
Elaine Hylek (USA)
Eric Peterson (USA)
Kenneth Mahaffey (USA)
L. Kristin Newby (USA)
Renato D. Lopes (USA)
Richard Becker (USA)
Robert Giugliano (USA)
NATIONAL FACULTY
Antonio Carlos C. de Carvalho
Gilson Soares Feitosa Filho
João Carlos de Campos Guerra
Marcia M. Barbosa
Márcio Vinicius Lins Barros
Maria da Consolação V. Moreira
Marildes Freitas
Otávio Berwanger
Renato Kalil
Roberto Rocha Giraldez
Thiago da Rocha Rodrigues
Scientific Program
OCTOBER 18, 2012
08:3009:00Opening
Renato D. Lopes, Richard C. Becker, David A. Garcia, Otavio Berwanger, Marcia Barbosa
e Maria da Consolação V. Moreira
09:0012:20
Chairmen: Richard C. Becker and Marcia Barbosa
09:0009:25
New Paradigms of Thrombosis
Richard C. Becker
09:3009:55
Update on New Antiplatelet and Anticoagulant Agents
Robert Giugliano
10:0010:25
The Most Important Changes in the ACCP Guidelines
David A. Garcia
10:30 10:50
Coffee Break
10:5011:15
Highlights of 2012 ASH, ACC and ESC Scientific Section Meetings
Roberto Rocha Giraldez
11:2011:45
Management of Anticoagulant-associated Bleeding: An Update
Richard C. Becker
11:5012:15
Debate: New oral anticoagulants that do not have an antidote should be avoided in clinical practice. For/Against:
Moderator: Kenneth Mahaffey
Christopher Granger and L. Kristin Newby
12:20 14:00
Lunch Break
14:0017:40
Chairmen: L. Kristin Newby and Antonio Carlos Carvalho
14:0014:25
Antithrombotic Therapy in medically managed patients with acute coronary syndromes
Robert Giugliano
14:3014:55
Antithrombotic Therapy in invasively treated patients with acute coronary syndromes
Eric Peterson
15:0015:25
Antithrombotic Therapy in New Devices for Heart Failure:
An Update
Maria da Consolação V. Moreira
15:3015:55
Antithrombotic Therapy in Patients with Congenital and Valvular
Heart Disease: Where Do We Stand in 2012?
Renato Kalil
16:00 16:25
Coffee Break
16:3016:55
Bleeding in patients with acute coronary syndrome: Importance and
management
L. Kristin Newby
17:0017:30
Cases discussion
Presenter: Antonio Carlos Carvalho
Panel: L. Kristin Newby, Christopher Granger, Robert Giugliano, Eric Peterson, Roberto Rocha Giraldez
OCTOBER 19, 2012
08:3012:40
Chairmen: David A. Garcia and Otavio Berwanger
08:3008:55 How do I decide who should receive DVT prophylaxis in clinical practice?
Gilson Soares Feitosa Filho
O9:0009:25
Critical view of DVT prophylaxis in medical patients. Where do we stand in 2012?
Otavio Berwanger
09:3009:55
Anticoagulation in the Elderly Population: Is there an Age Limit?
Maria da Consolação Vieira Moreira
10:0010:25
Carotid intima-media thickness test: An update of how to use it in
clinical Practice
Márcio Vinicius Lins Barros
10:3010:55
Diagnosis and Management of Heparin-induced thrombocytopenia: An update
João Carlos de Campos Guerra
11:00 11:30
Coffee Break
Scientific Program
OCTOBER 19, 2012
11:3011:55
Anticoagulation in Women: Where do we stand in 2012?
Marildes Freitas
12:0012:40
Cases discussion
Presenter: Gilson Soares Feitosa Filho
Panel: Otavio Berwanger, João Carlos de Campos Guerra, David Garcia,
Maria da Consolação Vieira Moreira, Richard C. Becker
12:40 14:00
Lunch Break
14:0018:00
Chairmen: Renato D. Lopes and Kenneth Mahaffey
14:0014:25
10 Key Lessons Learned from AF trials and registries
Elaine M. Hylek
14:3014:55
Intracranial Hemorrhage in patients treated with Warfarin: Where do we stand in 2012 and how can we manage it?
Eric Peterson
15:0015:25
Stroke and Bleeding risks in patients with AF: How should we assess them?
Renato D. Lopes
15:3015:55
Atrial Fibrillation and Heart Failure – What’s new?
Christopher B. Granger
16:00 16:20
Coffee Break
16:2516:50
How to manage anticoagulation in AF patients undergoing cardioversion?
Thiago da Rocha Rodrigues
16:5517:40
Debate: Patients with AF and stable INR: Should I switch them to new oral anticoagulants? Yes/No
Moderator: Eric Peterson
Kenneth Mahaffey and Elaine M. Hylek
17:4018:00
Closing Remarks
Richard Becker, David Garcia and Renato Lopes
Co-Chairs
Renato D. Lopes, MD, MHS, PhD
Associate Professor of Medicine
Department of Medicine - Division of Cardiology
Duke University
Executive Director
Brazilian Clinical Research Institute - BCRI
Richard C. Becker, MD
Professor of Medicine - Divisions of Cardiology and Hematology, Department of Medicine - Duke University Medical Center
Director of the Duke Cardiovascular Thrombosis Center
Duke Clinical Research Institute - DCRI
Co-Director of the Advanced Biomarkers Program
Duke Clinical Research Institute - DCRI
David A. Garcia, MD
Associate Professor, Internal Medicine
Division of Hematology / Oncology
University of New Mexico
Brazilian Co-Chairs
Marcia Barbosa, MD, PhD
Director, Ecocenter Socor Hospital
President-elected SIAC - Interamerican Society of Cardiology
Maria da Consolação V. Moreira, MD, PhD
Associate Professor of Medicine (Cardiology) of the Federal University of
Minas Gerais
Director of the Heart Failure and Heart Transplant Program
Otavio Berwanger, MD, PhD
Director of Research Institute HCor, Hospital do Coração,
Sao Paulo
Associate Faculty
Brazilian Clinical Research Institute – BCRI
Invited Speakers
Christopher B. Granger, MD
Professor of Medicine
Director - Cardiac Care Unit
Duke University Medical Center
David A. Garcia, MD
Associate Professor, Internal Medicine
Division of Hematology / Oncology
University of New Mexico
Elaine M. Hylek, MD, MPH
Associate Professor
Boston University School of Medicine
Director, Thrombosis Clinic and Anticoagulation Service
Boston Medical Center
Eric D. Peterson, MD, MPH
Fred Cobb, MD Distinguished Professor
Duke University Medical Center
Director
Duke Clinical Research Institute - DCRI
Invited Speakers
Kenneth Mahaffey, MD
Associate Professor of Medicine
Duke University Medical Center
Medical Director - Clinical Events Classification (CEC) Group
Faculty Leader Cardiovascular Mega Trials
Associate Director
Duke Clinical Research Institute
L. Kristin Newby, MD, MHS
Professor of Cardiovascular Medicine
Co-Director Cardiac Care Unit (Duke University Hospital)
Chairman Code Blue Committee (Duke University Hospital)
Duke Clinical Research Institute - DCRI
Duke University Medical Center
Renato D. Lopes, MD, MHS, PhD
Associate Professor of Medicine
Department of Medicine - Division of Cardiology
Duke University
Executive Director
Brazilian Clinical Research Institute – BCRI
Richard C. Becker, MD
Professor of Medicine - Divisions of Cardiology and Hematology, Department of Medicine - Duke University Medical Center
Director of the Duke Cardiovascular Thrombosis Center
Duke Clinical Research Institute - DCRI
Co-Director of the Advanced Biomarkers Program
Duke Clinical Research Institute - DCRI
Robert P. Giugliano, MD, SM, FACC, FAHA
Associate Physician in the Cardiovascular Division at the Brigham and
Women’s Hospital
Associate Professor of Medicine at Harvard Medical School
Antonio Carlos Carvalho, MD, PhD
Associate Professor of Medicine - Division of Cardiology
Federal University of Sao Paulo - UNIFESP
Scientific Director
Brazilian Clinical Research Institute – BCRI
Gilson S. Feitosa-Filho, MD, PhD
Adjunt Assistant Professor of Medicine
EBMSP (Escola Bahiana de Medicina e Saúde Pública)
Faculty Member of Cardiology at Hospital Santa Izabel
Santa Casa de Misericórdia da Bahia
Scientific Director of Brazilian Society of Cardiology - North-Northeast
João Carlos de Campos Guerra, MD
Medical Hematologist and Clinical Pathologist, specialist in Hematology
and Hemotherapy
Federal University of Sao Paulo – UNIFESP
Invited Speakers
Marcia Barbosa, MD, PhD
Director, Ecocenter Socor Hospital
President-elected SIAC - Interamerican Society of Cardiology
Marcio Vinicius Lins Barros, MD, PhD
Coordinator Echocardiography and Vascular Ultrasound Laboratory,
Materdei Hospital - Belo Horizonte - Brazil
Professor Cardiovascular Medicine - Faculdade de Saúde e Ecologia Humana
(FASEH) - Vespasiano - Brasil
Maria da Consolação V. Moreira, MD, PhD
Associate Professor of Medicine (Cardiology) of the Federal University of
Minas Gerais
Director of the Heart Failure and Heart Transplant Program
Marildes Freitas, MD
Cardiologist manager of SEC - Hospital João XXIII
Professor of cardiology of post graduation course IPEMED
Otavio Berwanger, MD, PhD
Director of Research Institute HCor, Hospital do Coração,
Sao Paulo
Associate Faculty
Brazilian Clinical Research Institute – BCRI
Renato Kalil, MD, PhD
Associate Professor
Division of Cardiac Surgery
Federal University of Porto Alegre
Scientific Director of the Brazilian Society of Cardiology
Roberto Rocha Giraldez, MD
Assistant Professor of Medicine - University of São Paulo
Cardiovascular Division - The Heart Institute - InCor
Associate Faculty
Brazilian Clinical Research Institute - BCRI
Thiago da Rocha Rodrigues, MD
Chief of Cardiology Department
Felício Rocho Hospital, Belo Horizonte, Minas Gerais
Director
Brazilian Society of Cardiac Arrhythmias – SOBRAC
Member of the Brazilian Society of Cardiology - SBC
Organization
Special Support
Support
With unrestricted educational grant from
BCRI - Brazilian Clinical Research Institute
Rua Pedro de Toledo, 314
CEP 04039 000 São Paulo SP
+ 55 11 5904 7339
Fax: + 55 11 5904 7331
www.ista2012.com.br
[email protected]
Ponto Zoom
Symposium Secretariat